Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BIO-TECHNE (TECH) EBITDA: 2009-2025

Historic EBITDA for BIO-TECHNE (TECH) over the last 17 years, with Jun 2025 value amounting to $91.8 million.

  • BIO-TECHNE's EBITDA fell 35.04% to $33.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.7 million, marking a year-over-year decrease of 56.31%. This contributed to the annual value of $91.8 million for FY2025, which is 41.08% down from last year.
  • Per BIO-TECHNE's latest filing, its EBITDA stood at $91.8 million for FY2025, which was down 41.08% from $155.9 million recorded in FY2024.
  • BIO-TECHNE's EBITDA's 5-year high stood at $294.4 million during FY2023, with a 5-year trough of $91.8 million in FY2025.
  • Its 3-year average for EBITDA is $180.7 million, with a median of $155.9 million in 2024.
  • In the last 5 years, BIO-TECHNE's EBITDA soared by 40.94% in 2022 and then crashed by 47.06% in 2024.
  • BIO-TECHNE's EBITDA (Yearly) stood at $180.3 million in 2021, then spiked by 40.94% to $254.1 million in 2022, then increased by 15.84% to $294.4 million in 2023, then tumbled by 47.06% to $155.9 million in 2024, then crashed by 41.08% to $91.8 million in 2025.